Limited expression of functional cytochrome p450 2c subtypes in the liver and small intestine of domestic cats

References

• Blaisdell J, Goldstein JA, Bai SA. (1998). Isolation of a new canine cytochrome P450 CDNA from the cytochrome P450 2C subfamily (CYP2C41) and evidence for polymorphic differences in its expression. Drug Metab Dispos 26:278–83.
   PubMed Web of Science ®Google Scholar
• Chaudhry AS, Prasad B, Shirasaka Y, et al. (2015). The CYP2C19 intron 2 branch point SNP is the ancestral polymorphism contributing to the poor metabolizer phenotype in livers with CYP2C19*35 and CYP2C19*2 alleles. Drug Metab Dispos 43:1226–35.
   PubMed Web of Science ®Google Scholar
• Chauret N, Gauthier A, Martin J, Nicoll-Griffith DA. (1997). In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metab Dispos 25:1130–6.
   PubMed Web of Science ®Google Scholar
• Court MH. (2013). Feline drug metabolism and disposition: pharmacokinetic evidence for species differences and molecular mechanisms. Vet Clin North Am Small Anim Pract 43:1039–54.
   PubMed Web of Science ®Google Scholar
• Daly AK, Rettie AE, Fowler DM, Miners JO. (2017 ). Pharmacogenomics of CYP2C9: functional and clinical considerations. J Pers Med 8:E1.
   PubMed Web of Science ®Google Scholar
• Donato MT, Jiménez N, Castell JV, Gómez-Lechón MJ. (2004). Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab Dispos 32:699–706.
   PubMed Web of Science ®Google Scholar
• Ferguson SS, Black K, Jackson JP. (2008). The CYP2C Subfamily. In: Ioannides C, eds. Cytochromes P450: role in the metabolism and toxicity of drugs and other xenobiotics. Cambridge: RSC Publishing, 200–240.
   Google Scholar
• Ghosal A, Hapangama N, Yuan Y, et al. (2003). Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes. Biopharm Drug Dispos 24:375–84.
   PubMed Web of Science ®Google Scholar
• Gómez-Lechón MJ, Donato T, Jover R, et al. (2001). Expression and induction of a large set of drug-metabolizing enzymes by the highly differentiated human hepatoma cell line BC2. Eur J Biochem 268:1448–59.
   PubMedGoogle Scholar
• Honda K, Komatsu T, Koyama F, et al. (2011). Expression of two novel cytochrome P450 3A131 and 3A132 in liver and small intestine of domestic cats. J Vet Med Sci 73:1489–92.
   PubMed Web of Science ®Google Scholar
• Ikushiro S, Sahara M, Emi Y, et al. (2004). Functional co-expression of xenobiotic metabolizing enzymes, rat cytochrome P450 1A1 and UDP-glucuronosyltransferase 1A6, in yeast microsomes. Biochim Biophys Acta 1672:86–92.
   PubMed Web of Science ®Google Scholar
• Isvoran A, Louet M, Vladoiu DL, et al. (2017). Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolism. Drug Discov Today 22:366–76.
   PubMed Web of Science ®Google Scholar
• Ito H, Fukuda Y, Murata K, Kimura A. (1983). Transformation of intact yeast cells treated with alkali cations. J Bacteriol 153:163–8.
   PubMed Web of Science ®Google Scholar
• Komatsu T, Honda K, Kubota A, et al. (2010). Molecular cloning and expression of cytochrome P450 2D6 in the livers of domestic cats. J Vet Med Sci 72:1633–6.
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis GM, Kanter R. (2006). Species difference between mouse rat dog monkey and human CYP mediated drug metabolism, inhibition, and induction. Expert Opin Drug Metab Toxicol 2:875–94.
   PubMed Web of Science ®Google Scholar
• Nakano M, Fukushima Y, Yokota S, et al. (2015). CYP2A7 pseudogene transcript affects CYP2A6 expression in human liver by acting as a decoy for miR-126. Drug Metab Dispos 43:703–12.
   PubMed Web of Science ®Google Scholar
• Niwa T, Imagawa Y. (2016). Substrate specificity of human cytochrome P450 (CYP) 2C subfamily and effect of azole antifungal agents on CYP2C8. J Pharm Pharm Sci 19:423–9.
   PubMed Web of Science ®Google Scholar
• Niwa T, Shiraga T, Yamasaki S, et al. (2003). In vitro activation of 7-benzyloxyresorufin O-debenzylation and nifedipine oxidation in human liver microsomes. Xenobiotica 33:717–29.
   PubMed Web of Science ®Google Scholar
• Okamatsu G, Kawakami K, Komatsu T, et al. (2017a). Functional expression and comparative characterization of four feline P450 cytochromes using fluorescent substrates. Xenobiotica 47:951–61.
   PubMed Web of Science ®Google Scholar
• Okamatsu G, Komatsu T, Kubota A, et al. (2015). Identification and functional characterization of novel feline cytochrome P450 2A. Xenobiotica 45:503–10.
   PubMed Web of Science ®Google Scholar
• Okamatsu G, Komatsu T, Ono Y, et al. (2017b). Characterization of feline cytochrome P450 2B6. Xenobiotica 47:93–102.
   PubMed Web of Science ®Google Scholar
• Oeda K, Sakaki T, Ohkawa H. (1985). Expression of rat liver cytochrome P-450MC cDNA in Saccharomyces cerevisiae. DNA. 4:203–10.
   PubMedGoogle Scholar
• Pearce R, Greenway D, Parkinson A. (1992). Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Arch Biochem Biophys 298:211–25.
   PubMed Web of Science ®Google Scholar
• Salminen KA, Leppänen J, Venäläinen JI, et al. (2011). Simple, direct, and informative method for the assessment of CYP2C19 enzyme inactivation kinetics. Drug Metab Dispos 39:412–8.
   PubMed Web of Science ®Google Scholar
• Shah SS, Sanda S, Regmi NL, et al. (2007). Characterization of cytochrome P450-mediated drug metabolism in cats. J Vet Pharmacol Ther 30:422–448.
   PubMed Web of Science ®Google Scholar
• Shimada T, Tsumura F, Yamazaki H. (1999). Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes. Drug Metab Dispos 27:1274–80.
   PubMed Web of Science ®Google Scholar
• Smith SA, Kraft SL, Lewis DC, Freeman LC. (2000). Plasma pharmacokinetics of warfarin enantiomers in cats. J Vet Pharmacol Ther 23:329–37.
   PubMed Web of Science ®Google Scholar
• Sudsakorn S, Skell J, Williams DA, et al. (2007). Evaluation of 3-O-methylfluorescein as a selective fluorometric substrate for CYP2C19 in human liver microsomes. Drug Metab Dispos 35:841–7.
   PubMed Web of Science ®Google Scholar
• Stresser DM, Blanchard AP, Turner SD, et al. (2000). Substrate-dependent modulation of CYP3A4 catalytic activity: Analysis of 27 test compounds with four fluorometric substrates. Drug Metab Dispos 28:1440–8.
   PubMed Web of Science ®Google Scholar
• Tanaka N, Miyasho T, Shinkyo R, et al. (2006). cDNA cloning and characterization of feline CYP1A1 and CYP1A2. Life Sci 79:2463–73.
   PubMed Web of Science ®Google Scholar
• Tanaka N, Shinkyo R, Sakaki T, et al. (2005). Cytochrome P450 2E polymorphism in feline liver. Biochim Biophys Acta 1726:194–205.
   PubMed Web of Science ®Google Scholar
• Tonn GR, Wong SG, Wong SC, et al. (2009). An inhibitory metabolite leads to dose- and time-dependent pharmacokinetics of (R)-N-{1-[3-(4-ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in human subjects after multiple dosing. Drug Metab Dispos 37:502–13.
   PubMed Web of Science ®Google Scholar
• Uehara S, Uno Y, Inoue T, et al. (2015). Novel marmoset cytochrome P450 2C19 in livers efficiently metabolizes human P450 2C9 and 2C19 substrates, S-warfarin, tolbutamide, flurbiprofen, and omeprazole. Drug Metab Dispos 43:1408–16.
   PubMed Web of Science ®Google Scholar
• Uno Y, Fujino H, Kito G, et al. (2006). CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone. Mol Pharmacol 70:477–86.
   PubMed Web of Science ®Google Scholar
• van Beusekom CD, Schipper L, Fink-Gremmels J. (2010). Cytochrome P450-mediated hepatic metabolism of new fluorescent substrates in cats and dogs. J Vet Pharmacol Ther 33:519–27.
   PubMed Web of Science ®Google Scholar
• van Beusekom CD, van den Heuvel JJ, Koenderink JB, et al. (2015). Feline hepatic biotransformation of diazepam: differences between cats and dogs. Res Vet Sci 103:119–25.
   PubMed Web of Science ®Google Scholar
• Watanabe KP, Kawai YK, Ikenaka Y, et al. (2013). Avian cytochrome P450 (CYP) 1-3 family genes: isoforms, evolutionary relationships, and mRNA expression in chicken liver. PLoS One 8:e75689.
   PubMed Web of Science ®Google Scholar